< Back to search
Filter
1
Active & Responsive

Intratumoral MMR Vaccine Injection in Borderline Resectable/Unresectable Pancreatic Cancer

for
Borderline Resectable/Unresectable Pancreatic Cancer,
Location: Little Rock AR
Sponsor: University of Arkansas

Sex: All

Age: 18+

Code: NCT07539155

Phase 1, Phase 2, Recruiting
Active & Responsive

Phase II Study Of Nivolumab Plus AVD In Pediatric, Adolescent, And Young Adult Patients With CHL

for
Hodgkin Lymphoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 2 - 21

Code: NCT07551583

Phase 2, Recruiting
Active & Responsive

Pilot Study of Ivonescimab in Advanced/Metastatic Cutaneous Angiosarcoma

for
Cutaneous Angiosarcoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT07655570

Phase 2, Recruiting
Active & Responsive

A Modular, Phase I/II, Multicentre Study to Evaluate AZD4045, in Participants With Relapsed or Refractory Multiple Myeloma

for
Relapsed or Refractory Multiple Myeloma
Location: Houston TX, Duarte CA
Sponsor: AstraZeneca

Sex: All

Age: 18+

Code: NCT07681596

Phase 1, Phase 2, Recruiting
Active & Responsive

Regorafenib (Reg) and Lorigerlimab (Lor), RELO Regimen, in Treatment of High-risk Patients With Colorectal Cancer With Radiographic Occult Molecular Residual Disease After End of Established Definitive Therapy [ReLOAD Trial]

for
Colorectal Cancer, Regorafenib, High Risk Patients
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT07071961

Phase 2, Recruiting

Interested in new solid tumors trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Phase I/IIa Dose Finding Study of Triplet Regimen of Relatlimab Ipilimumab and NIvolumab in First Line Therapy of Metastatic Melanoma (TRINITY)

for
Melanoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06683755

Phase 1, Phase 2, Recruiting
Active & Responsive

Ziftomenib for the Treatment of Patients With NPM1 Mutated or KMT2A Rearranged Acute Myeloid Leukemia Not Eligible for Standard Therapy

for
Acute Myeloid Leukemia
Location: Columbus OH
Sponsor: Uma Borate

Sex: All

Age: 18+

Code: NCT06930352

Phase 2, Recruiting
Active & Responsive

Measuring Circulating Tumor Deoxyribonucleic Acid Tumor Fraction to Guide Early 177Lu-PSMA-617 Treatment Discontinuation in Patients With Metastatic Castration-Resistant Prostate Cancer, DYNAMO Trial

for
Metastatic Castration-Resistant Prostate Adenocarcinoma,
Location: Seattle WA
Sponsor: University of Washington

Sex: Male

Age: 18+

Code: NCT07698535

Phase 2, Recruiting
Active & Responsive

Feasibility of Remote Monitoring of Patients With Myasthenia Gravis

for
Myasthenia Gravis (MG)
Location: Washington D.C. DC
Sponsor: George Washington University

Sex: All

Age: 18+

Code: NCT07787247

Recruiting
Active & Responsive

Bridging Adolescent and Young Adult Sarcoma Survivors With Personalized Oncology Exercise Service (AYA-ONE): A Pilot Intervention

for
Sarcoma, Bone Sarcoma, Soft Tissue Sarcoma (STS)
Location: Boston MA
Sponsor: Dana-Farber Cancer Institute

Sex: All

Age: 15 - 39

Code: NCT07662239

Recruiting
Active & Responsive

e-Health Psychosocial Stress and Symptom Management (ePSMI) for Pancreatic Cancer Patients

for
Pancreatic Cancer
Location: Miami FL
Sponsor: University of Miami

Sex: All

Age: 18+

Code: NCT06893276

Recruiting
Active & Responsive

Samuraciclib for the Treatment of Patients With Resectable, Borderline Resectable, or Locally Advanced Basal Pancreatic Cancer

for
Resectable Pancreatic Ductal Adenocarcinoma,
Location: Seattle WA
Sponsor: University of Washington

Sex: All

Age: 18+

Code: NCT07645651

Phase 1, Recruiting
Active & Responsive

A Study to Identify Breast Cancer (IDBC)

for
Breast Cancer Female
Location: Calgary
Sponsor: Syantra Inc.

Sex: Female

Age: 30 - 70+

Code: NCT04495244

Recruiting
Active & Responsive

A Phase 1 and 2 Study of VMD-102 in Hepatocellular Carcinoma and Other Solid Tumors

for
Hepatocellular Carcinoma (HCC), Metastatic Uveal Melanoma,
Location: Scottsdale AZ
Sponsor: VM Discovery, Inc.

Sex: All

Age: 18 - 70+

Code: NCT07636785

Phase 1, Phase 2, Recruiting
Active & Responsive

Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation

for
CNS Embryonal Tumor, CNS, Medulloblastoma,
Location: Quebec, Sherbrooke, Montreal, Toronto, Hamilton, London,
Sponsor: C17 Council

Sex: All

Age: 0 - 6

Code: NCT06942039

Early Phase 1, Recruiting
Active & Responsive

Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors

for
Somatostatin Receptor Positive, NETs, Lymphoma, Solid Tumor,
Location: Philadelphia PA, Cincinnati OH, Houston TX,
Sponsor: ITM Solucin GmbH

Sex: All

Age: 2 - 18

Code: NCT06441331

Phase 1, Recruiting
Active & Responsive

Fish Oil, Metformin and Heart Health in PCOS

for
PCOS, Cardiovascular Disease,
Location: Edmonton
Sponsor: University of Alberta

Sex: Female

Age: 25 - 45

Code: NCT06424860

Phase 1, Recruiting
Active & Responsive

Novel Couple-Based Mindfulness Intervention for Metastatic Colorectal Cancer

for
Colorectal Cancer, Metastatic Colorectal Cancer (CRC)
Location: Aurora CO
Sponsor: University of Colorado, Denver

Sex: All

Age: 18 - 70+

Code: NCT07759921

Recruiting
Active & Responsive

A Blended e-Health Intervention to Improve Fear of Progression in Women With Gynecologic or Breast Cancer

for
Anatomic Stage I Breast Cancer AJCC v8,
Location: Upland CA, Irvine CA, Lancaster CA, Duarte CA,
Sponsor: City of Hope Medical Center

Sex: Female

Age: 18+

Code: NCT07741968

Recruiting
Active & Responsive

A PET Imaging Agent (64Cu-DOTA-Pembrolizumab) for Determining Treatment Response Among Patients With Stage IV Non-small Cell Lung Cancer Receiving Pembrolizumab

for
Metastatic Lung Non-Small Cell Carcinoma,
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 18+

Code: NCT07619599

Phase 1, Recruiting